LTR Pharma's Chief Scientific and Clinical Advisor, Professor Eric Chung, was awarded the prestigious BAUS Trophy at the Urological Society of Australia and New Zealand (USANZ) Annual Scientific Meeting held in Perth this week for his presentation of SPONTAN® clinical trial data.The BAUS Trophy is considered the most prestigious award at the USANZ Annual Scientific Meeting and recognises excellence in presentation, content originality, and scientific discussion quality.His presentation, which showcased SPONTAN's breakthrough clinical results demonstrating 5 x faster absorption than oral ED tablets, was judged by a panel of peers to be the most outstanding scientific podium presentation at the conference.LTR Pharma extends its congratulations to Professor Chung for his diligent work in building awareness of SPONTAN's profile within the medical community, further strengthening the Company's position as it advances its commercial and regulatory strategies across key markets.
LTP Price at posting:
55.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)